F. Russano

A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

F. Bassetto, S. Mocellin, V. Chiarion Sileni, 2020, Frontiers in Oncology.

Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020)

J. Gehl, B. Silvestri, G. Serša, 2022, Frontiers in Oncology.

The Role of Electrochemotherapy in the Cutaneous and Subcutaneous Metastases From Breast Cancer: Analysis of Predictive Factors to Treatment From an Italian Cohort of Patients

S. Mocellin, A. Parisi, G. Scarzello, 2021, Frontiers in Oncology.

Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET).

S. Mocellin, M. Montesco, I. Ray-Coquard, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143)

F. Bassetto, S. Mocellin, A. D. Dei Tos, 2021, Frontiers in Oncology.

TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial

S. Mocellin, V. Chiarion-Sileni, D. Nitti, 2008, Annals of Surgical Oncology.

Management of melanoma patients during COVID‐19 pandemic in an Italian skin unit

S. Mocellin, A. Filoni, A. Buja, 2021, Dermatologic therapy.

Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study

S. Mocellin, A. D. Dei Tos, V. Chiarion-Sileni, 2021, Frontiers in Oncology.

Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study

F. Bassetto, S. Mocellin, A. D. Dei Tos, 2021, Frontiers in Oncology.

Efficacy of Electrochemotherapy in Breast Cancer Patients of Different Receptor Status: The INSPECT Experience

J. Gehl, B. Silvestri, F. Terlizzi, 2023, Cancers.